ProMetic Life Sciences (PLI) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for ProMetic Life Sciences (TSE: PLI):

  • 10/13/2016 – ProMetic Life Sciences had its “hold” rating reaffirmed by analysts at BLOOM BURTON&CO.
  • 10/13/2016 – ProMetic Life Sciences had its “outperform” rating reaffirmed by analysts at Scotiabank. They now have a C$5.00 price target on the stock.
  • 10/13/2016 – ProMetic Life Sciences had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada.
  • 9/28/2016 – ProMetic Life Sciences had its “speculative buy” rating reaffirmed by analysts at TD Securities. They now have a C$4.50 price target on the stock.
  • 8/25/2016 – ProMetic Life Sciences had its “outperform” rating reaffirmed by analysts at Scotiabank. They now have a C$5.00 price target on the stock.
  • 8/25/2016 – ProMetic Life Sciences had its price target lowered by analysts at CIBC from C$5.00 to C$4.85.
  • 8/25/2016 – ProMetic Life Sciences had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada.

Shares of ProMetic Life Sciences Inc. (TSE:PLI) traded up 0.32% during midday trading on Wednesday, reaching $3.12. 1,008,320 shares of the company’s stock traded hands. ProMetic Life Sciences Inc. has a 52-week low of $1.67 and a 52-week high of $3.62. The company has a 50 day moving average of $2.95 and a 200 day moving average of $3.00. The firm’s market cap is $1.89 billion.

ProMetic Life Sciences Inc (ProMetic) is a Canada-based biopharmaceutical company. The Company has two segments: Small Molecule Therapeutics and Protein Technology. The Company offers its technology platform for large-scale drug purification of biologics, drug development, proteomics and the elimination of pathogens to various industries, and uses its own affinity technology that provides for extraction and purification of therapeutic proteins from human plasma in order to develop therapeutics and orphan drugs.

Receive News & Ratings for ProMetic Life Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMetic Life Sciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

GoPro Planning to Cut 200 Jobs
GoPro Planning to Cut 200 Jobs
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Retailers Anticipating Strong Support for Small Business Saturday
Retailers Anticipating Strong Support for Small Business Saturday
Eli Lilly Alzheimer’s Drug Does Not Pass the Test
Eli Lilly Alzheimer’s Drug Does Not Pass the Test
Disney to Build Larger Hong Kong Kingdom
Disney to Build Larger Hong Kong Kingdom
DraftKings and FanDuel Finally Will Merge
DraftKings and FanDuel Finally Will Merge


 
© 2006-2016 Ticker Report. Google+.